Schizophrenia Research
Volume 88, Issue 1 , Pages 47-54 , December 2006

Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: A 10-year follow-up study

  • Ruud van Winkel

      Affiliations

    • University Psychiatric Center Katholieke Universiteit Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
    • Department of Psychiatry and Neuropsychology, EURON, South Limburg Mental Health Research and Teaching Network, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Inez Myin-Germeys

      Affiliations

    • Department of Psychiatry and Neuropsychology, EURON, South Limburg Mental Health Research and Teaching Network, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Philippe Delespaul

      Affiliations

    • Department of Psychiatry and Neuropsychology, EURON, South Limburg Mental Health Research and Teaching Network, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Jozef Peuskens

      Affiliations

    • University Psychiatric Center Katholieke Universiteit Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
    • ,
  • Marc De Hert

      Affiliations

    • University Psychiatric Center Katholieke Universiteit Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
    • ,
  • Jim van Os

      Affiliations

    • Department of Psychiatry and Neuropsychology, EURON, South Limburg Mental Health Research and Teaching Network, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • Division of Psychological Medicine, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK
    • Corresponding Author InformationCorresponding author. Department of Psychiatry and Neuropsychology, European Graduate School of Neuroscience, Maastricht University, PO Box 616 (DRT10), 6200 MD Maastricht, The Netherlands. Tel.: +31 43 3875443; fax: +31 43 3875444.

Received 14 December 2005 ,Revised 23 June 2006 ,Accepted 24 June 2006.

References 

  1. Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr. Res. 2005;78(1):35–43
  2. Amminger G, Schlogelhofer M, Lehner T, Looser Ott S, Friedrich M, Aschauer H. Premorbid performance IQ deficit in schizophrenia. Acta Psychiatr. Scand. 2000;102(6):414–422
  3. Antonova E, Sharma T, Morris R, Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr. Res. 2004;70(2–3):117–145
  4. Antonova E, Kumari V, Morris R, Halari R, Anilkumar A, Mehrotra R, et al. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study. Biol. Psychiatry. 2005;58(6):457–467
  5. Bilder R, Lipschutz-Broch L, Reiter G, Geisler S, Mayerhoff D, Lieberman J. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr. Bull. 1992;18(3):437–448
  6. Bleuler E. Dementia Praecox or the Group of Schizophrenias. New York: International Universities Press; 1950;
  7. Bryson G, Greig T, Lysaker P, Bell M. Longitudinal Wisconsin Card Sorting performance in schizophrenia patients in rehabilitation. Appl. Neuropsychol. 2002;9(4):203–209
  8. Carpenter W, Arango C, Buchanan R, Kirkpatrick B. Deficit psychopathology and a paradigm shift in schizophrenia research. Biol. Psychiatry. 1999;46(3):352–360
  9. Caspi A, Reichenberg A, Weiser M, Rabinowitz J, Kaplan Z, Knobler H, et al. Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr. Res. 2003;65(2–3):87–94
  10. Clayton D, Hills M. Wald Tests. Oxford: Oxford University Press; 1993;
  11. Crow T. Molecular pathology of schizophrenia: more than one disease process?. Br. Med. J. 1980;280(6207):66–68
  12. David A. Letter to the editor. Am. J. Psychiatry. 1998;155(11):1626
  13. DeQuardo J, Tandon R, Goldman R, Meador-Woodruff J, McGrath-Giroux M, Brunberg J, et al. Ventricular enlargement, neuropsychological status, and premorbid function in schizophrenia. Biol. Psychiatry. 1994;35(8):517–524
  14. Flynn JR. Massive IQ gains in 14 nations: what IQ tests really measure. Psychol. Bull. 1987;101:171–191
  15. Friedman J, Harvey PD, Coleman T, Moriarty P, Bowie C, Parrella M, et al. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am. J. Psychiatry. 2001;158(9):1441–1448
  16. Friedman J, Harvey PD, McGurk S, White L, Parrella M, Raykov T, et al. Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity. Am. J. Psychiatry. 2002;159(8):1388–1394
  17. Fuller R, Nopoulos P, Arndt S, O'Leary D, Ho B, Andreasen N. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am. J. Psychiatry. 2002;159(7):1183–1189
  18. Garver D, Holcomb J, Christensen J. Heterogeneity of response to antipsychotics from multiple disorders in the schizophrenia spectrum. J. Clin. Psychiatry. 2000;61(12):964–972
  19. Gold S, Arndt S, Nopoulos P, O'Leary D, Andreasen N. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am. J. Psychiatry. 1999;156(9):1342–1348
  20. Goldstein H. Multilevel Models in Educational and Social Research, Griffin, London. 1987;
  21. Gunnell D, Harrison G, Rasmussen F, Fouskakis D, Tynelius P. Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia: cohort study. Br. J. Psychiatry. 2002;181(4):298–305
  22. Heaton R, Gladsjo J, Palmer B, Kuck J, Marcotte T, Jeste D. Stability and course of neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry. 2001;58(1):24–32
  23. Hoff A, Sakuma M, Wieneke M, Horon R, Kushner M, DeLisi L. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am. J. Psychiatry. 1999;156(9):1336–1341
  24. Hoff AL, Svetina C, Shields G, Stewart J, DeLisi LE. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr. Res. 2005;78(1):27–34
  25. Jay T, Rocher C, Hotte M, Naudon L, Gurden H, Spedding M. Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases. Neurotox. Res. 2004;6(3):233–244
  26. Kraepelin E. Dementia praecox and paraphrenia. In:  Robertson G,  Livingstone S editor. Textbook of Psychiatry. Edinborough: Chicago Medical Book Company; 1919;
  27. Kurtz M. Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophr. Res. 2005;74(1):15–26
  28. Lieberman J, Alvir J, Koreen A, Geisler S, Chakos M, Sheitman B, et al. Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology. 1996;14(3 Suppl):S13–S21
  29. Mas M. Vragenlijst voor Intellectuele Status. Lisse: Swets and Zeitlinger; 1979;
  30. McCormick L, Flaum M. Diagnosing schizophrenia circa 2005: how and why?. Curr. Psychiatry Rep. 2005;7(4):311–315
  31. Murray R, O'Callaghan E, Castle D, Lewis S. A neurodevelopmental approach to the classification of schizophrenia. Schizophr. Bull. 1992;18(2):319–332
  32. Myin-Germeys I, Krabbendam L, Jolles J, Delespaul P, van Os J. Are cognitive impairments associated with sensitivity to stress in schizophrenia? An experience sampling study. Am. J. Psychiatry. 2002;159(3):443–449
  33. Myin-Germeys I, Krabbendam L, Delespaul P, van Os J. Can cognitive deficits explain differential sensitivity to life events in psychosis?. Soc. Psychiatry Psychiatr. Epidemiol. 2003;38(5):262–268
  34. Myin-Germeys I, Krabbendam L, Delespaul P, van Os J. Sex differences in emotional reactivity to daily life stress in psychosis. J. Clin. Psychiatry. 2004;65(6):805–809
  35. Myin-Germeys I, Marcelis M, Krabbendam L, Delespaul P, van Os J. Subtle fluctuations in psychotic phenomena as functional states of abnormal dopamine reactivity in individuals at risk. Biol. Psychiatry. 2005;58(2):105–110
  36. Nelson H, Pantelis C, Carruthers K, Speller J, Baxendale S, Barnes T. Cognitive functioning and symptomatology in chronic schizophrenia. Psychol. Med. 1990;20(2):357–365
  37. O'Carroll R, Walker M, Dunan J, Murray R, Blackwood D, Ebmeier K, et al. Selecting controls for schizophrenia research studies: the use of the National Adult Reading Test (NART) is a measure of premorbid ability. Schizophr. Res. 1992;8(2):137–141
  38. Rabinowitz J, Reichenberg A, Weiser M, Mark M, Kaplan Z, Davidson M. Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital: cross-sectional analysis. Br. J. Psychiatry. 2000;177(1):26–32
  39. Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch. Gen. Psychiatry. 2005;62(12):1297–1304
  40. Robins E, Guze S. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am. J. Psychiatry. 1970;126(7):983–987
  41. Rund B. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr. Bull. 1998;24(3):425–435
  42. Russell A, Munro J, Jones P, Hemsley D, Murray R. Schizophrenia and the myth of intellectual decline. Am. J. Psychiatry. 1997;154(5):635–639
  43. Russell A, Munro J, Jones P, Hayward P, Hemsley D, Murray R. The National Adult Reading Test as a measure of premorbid IQ in schizophrenia. Br. J. Clin. Psychol. 2000;39(3):297–305
  44. Sham P, Castle D, Wessely S, Farmer A, Murray R. Further exploration of a latent class typology of schizophrenia. Schizophr. Res. 1996;20(1–2):105–115
  45. Shatz M. WAIS practice effects in clinical neuropsychology. J. Clin. Neuropsychol. 1981;3(2):171–179
  46. Stinissen J. De overgang van secundair naar hoger onderwijs. Een follow-up van 6000 abituriënten. Rapport 1: Uitgangspunten en dataverzameling. Rapport 2: De eindsituatie van het secundair onderwijs. Rapport 3: Doorstromen en slagen. Leuven: Acco; 1987;
  47. Stinissen J, Willems P, Coetsier . WAIS. Nederlandstalige Bewerking. Lisse: Swets & Zeitlinger; 1970;
  48. Tamminga C, Buchanan R, Gold J. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int. Clin. Psychopharmacol. 1998;13(Suppl 3):S21–S26
  49. Wechsler D. WAIS-III, Nederlandstalige Bewerking, Technische Handleiding. Lisse: Swets Test Publishers; 1997;
  50. Zampera E. Intellectual performance of chronic schizophrenic patients. Coll. Antropol. 1999;23(2):597–602

PII: S0920-9964(06)00301-X

doi: 10.1016/j.schres.2006.06.033

Schizophrenia Research
Volume 88, Issue 1 , Pages 47-54 , December 2006

Article Tools